BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+4.43%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$956M
AUM Growth
+$956M
(+13%)
Cap. Flow
+$86.3M
Cap. Flow
% of AUM
9.03%
Top 10 Holdings %
Top 10 Hldgs %
34.18%
Holding
136
New
4
Increased
64
Reduced
26
Closed
5
Top Buys
| 1 |
Illumina
ILMN
|
$11M |
| 2 |
Align Technology
ALGN
|
$10.5M |
| 3 |
CELG
Celgene Corp
CELG
|
$10.3M |
| 4 |
Elevance Health
ELV
|
$9.07M |
| 5 |
Gilead Sciences
GILD
|
$7.35M |
Top Sells
| 1 |
Medtronic
MDT
|
$6.88M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$5.81M |
| 3 |
Cigna
CI
|
$5.21M |
| 4 |
Centene
CNC
|
$4.92M |
| 5 |
BCR
CR Bard Inc.
BCR
|
$4.66M |
Sector Composition
| 1 | Healthcare | 94.19% |
| 2 | Financials | 0.94% |
| 3 | Industrials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
76
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.45M | 0.26% | 45,000 +6,000 | +15% | +$326K |
|
77
Prothena Corp
PRTA
$441M
| $2.42M | 0.25% | 37,400 -3,600 | -9% | -$233K |
|
78
Ultragenyx Pharmaceutical
RARE
$2.89B
| $2.24M | 0.23% | 42,000 | – | – |
|
79
DexCom
DXCM
$29.5B
| $2.2M | 0.23% | 45,000 +7,500 | +20% | +$367K |
|
80
Healthcare Services Group
HCSG
$1.13B
| $2.05M | 0.21% | 38,000 +1,500 | +4% | +$81K |
|
81
Qiagen
QGEN
$10.1B
| $1.94M | 0.2% | 61,611 -17,833 | -22% | -$562K |
|
|
JUNO
82
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.93M | 0.2% | 43,000 | – | – |
|
|
CYTO
83
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $1.78M | 0.19% | 2,169,625 | – | – |
|
|
IPXL
84
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.77M | 0.18% | 87,000 -88,000 | -50% | -$1.79M |
|
85
Merck
MRK
$210B
| $1.76M | 0.18% | 27,500 | – | – |
|
86
HUTCHMED
HCM
$2.58B
| $1.75M | 0.18% | 64,573 +35,331 | +121% | +$958K |
|
87
AngioDynamics
ANGO
$417M
| $1.74M | 0.18% | 101,700 | – | – |
|
88
iRhythm Technologies
IRTC
$5.46B
| $1.73M | 0.18% | 33,400 +9,900 | +42% | +$514K |
|
|
PTLA
89
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.7M | 0.18% | 31,500 -4,500 | -13% | -$243K |
|
90
HCA Healthcare
HCA
$94.5B
| $1.7M | 0.18% | 21,300 | – | – |
|
91
Globus Medical
GMED
$8.27B
| $1.64M | 0.17% | 55,000 +15,000 | +38% | +$446K |
|
92
Teladoc Health
TDOC
$1.37B
| $1.56M | 0.16% | 47,000 +24,500 | +109% | +$812K |
|
|
CLVS
93
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.52M | 0.16% | 18,500 | – | – |
|
94
Halozyme
HALO
$8.56B
| $1.52M | 0.16% | 87,600 -131,400 | -60% | -$2.28M |
|
95
Penumbra
PEN
$10.6B
| $1.52M | 0.16% | 16,800 +5,500 | +49% | +$497K |
|
|
TRHC
96
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.48M | 0.16% | 55,407 +18,500 | +50% | +$495K |
|
97
Acadia Healthcare
ACHC
$2.12B
| $1.48M | 0.15% | +31,000 | New | +$1.48M |
|
98
Masimo
MASI
$7.59B
| $1.47M | 0.15% | 17,000 | – | – |
|
|
TSRO
99
DELISTED
TESARO, Inc.
TSRO
| $1.42M | 0.15% | 11,000 -8,000 | -42% | -$1.03M |
|
|
RDUS
100
DELISTED
Radius Health, Inc.
RDUS
| $1.41M | 0.15% | 36,500 | – | – |
|